Enhanced activity of human serotonin transporter variants associated with autism
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Rare, functional, non-synonymous variants in the human serotonin (5-hydroxytryptamine, 5-HT) transporter (hSERT) gene (SLC6A4) have been identified in both autism and obsessive–compulsive disorder (OCD). Within autism, rare hSERT coding variants associate with rigid–compulsive traits, suggesting both phenotypic overlap with OCD and a shared relationship with disrupted 5-HT signalling. Here, we document functional perturbations of three of these variants: Ile425Leu; Phe465Leu; and Leu550Val. In transiently transfected HeLa cells, the three variants confer a gain of 5-HT transport phenotype. Specifically, enhanced SERT activity was also observed in lymphoblastoid lines derived from mutation carriers. In contrast to previously characterized Gly56Ala, where increased transport activity derives from catalytic activation, the three novel variants exhibit elevated surface density as revealed through both surface antagonist-binding and biotinylation studies. Unlike Gly56Ala, mutants Ile425Leu, Phe465Leu and Leu550Val retain a capacity for acute PKG and p38 MAPK regulation. However, both Gly56Ala and Ile425Leu demonstrate markedly reduced sensitivity to PP2A antagonists, suggesting that deficits in trafficking and catalytic modulation may derive from a common basis in perturbed phosphatase regulation. When expressed stably from the same genomic locus in CHO cells, both Gly56Ala and Ile425Leu display catalytic activation, accompanied by a striking loss of SERT protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lord, C., Cook, E. H., Leventhal, B. L., & Amaral, D. G. (2000) · Neuron · doi:10.1016/s0896-6273(00)00115-x · Cited by 555
Sutcliffe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L., Li, C., Folstein, S. E., & Blakely, R. D. (2005) · The American Journal of Human Genetics · doi:10.1086/432648 · Cited by 392
Self-citationSerotonin as a developmental signal
Whitaker-Azmitia, P. M., Druse, M., Walker, P., & Lauder, J. M. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00071-x · Cited by 356 · cited 1×
“Rodent studies demonstrate a significant effect on brain structure (Persico et al. 2003; Altamura et al. 2007) and behaviour (Holmes et al. 2002, 2003) following genetic or pharmacological manipulations of SERTand/ or 5-HT during development (Whitaker-Azmitia et al. 1996; Bengel et al. 1998).”
BackgroundZhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Self-citationCarneiro, A. M. D., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33374 · Cited by 180 · cited 4×
“Finally, we recently documented the physical association and regulation of SERT by integrin b3 (Carneiro et al. 2008).”
BackgroundEvidence for Sex-Specific Risk Alleles in Autism Spectrum Disorder
Stone, J. L., Merriman, B., Cantor, R. M., Yonan, A. L., Gilliam, T. C., Geschwind, D. H., & Nelson, S. F. (2004) · The American Journal of Human Genetics · doi:10.1086/426034 · Cited by 176
Replication of Autism Linkage: Fine-Mapping Peak at 17q21
Cantor, R. M., Kono, N., Duvall, J. A., Alvarez-Retuerto, A., Stone, J. L., Alarcón, M., Nelson, S. F., & Geschwind, D. H. (2005) · The American Journal of Human Genetics · doi:10.1086/430278 · Cited by 157 · cited 1×
“2– 17q21 (Cook et al. 1997; McCauley et al. 2004; Stone et al. 2004; Cantor et al. 2005; Sutcliffe et al. 2005).”
Glatt, C. E., DeYoung, J. A., Delgado, S., Service, S. K., Giacomini, K. M., Edwards, R. H., Risch, N., & Freimer, N. B. (2001) · Nature Genetics · doi:10.1038/86948 · Cited by 154
Jayanthi, L. D., Samuvel, D. J., Blakely, R. D., & Ramamoorthy, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009555 · Cited by 123
Self-citationAltamura, C., Dell'Acqua, M., Moessner, R., Murphy, D., Lesch, K., & Persico, A. M. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl051 · Cited by 79
Cited by
Behavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462
“Neurotransmission genes, including the serotonin transporter, oxytocin and vasopressin receptors and GABA (γ-aminobutyric acid) receptor subunit β3, have been repeatedly associated with autism or highly implicated in social and affiliative behaviours impaired in autis”
BackgroundSLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
“Moreover, these findings were subsequently confirmed in heterologous cell systems devoid of potential genetic modifiers of SERT (Prasad et al., 2009).”
BackgroundVeenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A., Shah, C. R., Cohen, J., Mannangatti, P., Jessen, T., Thompson, B. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112345109 · Cited by 333
“Consistent with our findings in transfected cells (14, 15), we found phosphorylation of SERT Ala56 to be significantly elevated in midbrain synaptosomes under basal conditions (P = 0.”
BackgroundResultInfluentialSelf-citationSLC6 transporters: Structure, function, regulation, disease association and therapeutics
Pramod, A. B., Foster, J., Carvelli, L., & Henry, L. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.002 · Cited by 319
Zhu, C.-B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D., & Hewlett, W. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.116 · Cited by 317
Self-citationGastrointestinal issues in autism spectrum disorder
Hsiao, E. Y. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000029 · Cited by 209
Tye, C., Runicles, A. K., Whitehouse, A. J. O., & Alvares, G. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00751 · Cited by 177
“In addition, alterations in the serotonin reuptake transporter (SERT) are implicated in ASD (157)”
Vesicular and Plasma Membrane Transporters for Neurotransmitters
Blakely, R. D., & Edwards, R. H. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005595 · Cited by 169
“Five additional SERT variants were then also identified in ASD, and all confer a gain of function (Sutcliffe et al. 2005; Prasad et al. 2009).”
BackgroundSelf-citationUllrich (2018) · doi:10.1038/mp.2017.188 · Cited by 145
Margolis, K. G., Li, Z., Stevanovic, K., Saurman, V., Israelyan, N., Anderson, G. M., Snyder, I., Veenstra-VanderWeele, J., Blakely, R. D., & Gershon, M. D. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84877 · Cited by 139
Self-citationVeenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
“As common SLC6A4 variants did not explain the strong linkage signal on 17q, the Sutcliffe and Blakely labs searched for rare variants (Sutcliffe et al, 2005) and identified multiple, rare non-synonymous variants, with each demonstrating increased 5-HT uptake (Prasad et al, 2009, 2005).”
BackgroundSelf-citationSerotonin as a link between the gut-brain-microbiome axis in autism spectrum disorders
Israelyan, N., & Margolis, K. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.020 · Cited by 122
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters
Bermingham, D. P., & Blakely, R. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012260 · Cited by 97
Self-citationHung, L. Y., & Margolis, K. G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00857-1 · Cited by 96
Neuron Membrane Trafficking and Protein Kinases Involved in Autism and ADHD
Kitagishi, Y., Minami, A., Nakanishi, A., Ogura, Y., & Matsuda, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023095 · Cited by 37
“Enhanced activity of serotonin transporter variants is also associated with autisms [96].”
BackgroundInsomnia in Children Affected by Autism Spectrum Disorder: The Role of Melatonin in Treatment
Bruni, O., Biggio, G., Malorgio, E., & Nobili, L. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.05.046 · Cited by 11
O’Reilly, K. C., Anacker, A. M. J., Rogers, T. D., Forsberg, C. G., Wang, J., Zhang, B., Blakely, R. D., & Veenstra-VanderWeele, J. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135027 · Cited by 8
“Although the Ala56 variant represents a very minor change in the SERT, in vitro [10] and in vivo [2] studies reveal significant biochemical, physiological and behavioral effects, including modulation of trait domains altered in ASD.”
BackgroundSelf-citation
Metadata
- Authors
- Prasad, H. C., Steiner, J. A., Sutcliffe, J. S., & Blakely, R. D.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2008-10-28
- Volume
- 364
- Issue
- 1514
- Pages
- 163-173
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2141910384
- Cited by
- 126
- References
- 10
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.